Executive Director, Asset Strategy & Biomarker Innovation

Recursion; United States; Remote; USD 180,000 - 280,000; Full time

Job summary

Recursion is seeking a strategic leader to define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation, integrating competitive positioning and biomarker strategy.

You will translate Recursion OS and ClinTech insights into strategic advantages, ensuring proprietary data and computational insights maximize drug discovery and development, and partner with clinical development, BD, finance and platform leaders to align resources with conviction and

Responsibilities

• Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation, integrating competitive positioning and biomarker strategy.
• Translate Recursion OS and ClinTech insights into strategic advantages, ensuring proprietary data and computational insights maximally enable drug discovery and development.
• Partner with functional leaders across clinical development, BD, finance, and platform teams to align resource allocation with strategic conviction and impact.

Job description

Recursion is seeking a strategic leader to define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation, integrating competitive positioning and biomarker strategy.

You will translate Recursion OS and ClinTech insights into strategic advantages, ensuring proprietary data and computational insights maximize drug discovery and development, and partner with clinical development, BD, finance and platform leaders to align resources with conviction and